Cite
HARVARD Citation
Infante, J. et al. (2013). Axitinib and/or bevacizumab with modified FOLFOX‐6 as first‐line therapy for metastatic colorectal cancer: A randomized phase 2 study. Cancer. 119 (14), pp. 2555-2563. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Infante, J. et al. (2013). Axitinib and/or bevacizumab with modified FOLFOX‐6 as first‐line therapy for metastatic colorectal cancer: A randomized phase 2 study. Cancer. 119 (14), pp. 2555-2563. [Online].